Table 1.
Demographic characteristics and clinical variables data in the study groups
| MCF <50 mm (n=16) (%) | MCF ≥50 mm (n=44) (%) | P | |
|---|---|---|---|
| Gender | |||
| Male | 16 (100) | 38 (86.4) | 0.179 |
| Female | 0 | 6 (13.6) | |
| Age (year) | 60.56±7.38 | 61.11±10.58 | 0.849 |
| Operating room working shift | |||
| Morning 8:00-14:00 | 5 (31.3) | 11 (25) | 0.021 |
| Evening 14:00-19:00 | 1 (6.3) | 19 (43.2) | |
| Night 19:00-8:00 | 10 (62.5) | 14 (31.8) | |
| Cigarette smoking | 7 (43.8) | 19 (43.2) | 1.000 |
| Diabetes mellitus | 9 (56.3) | 17 (38.6) | 0.252 |
| Dyslipidemia | 1 (6.3) | 19 (43.2) | 0.011 |
| Hypertension | 3 (18.8) | 31 (70.5) | 0.001 |
| Recent myocardial infarction (<1 months) | 5 (31.3) | 23 (52.3) | 0.242 |
| Nitrates | 11 (68.8) | 21 (47.7) | 0.242 |
| β-blockers | 12 (75) | 28 (63.6) | 0.567 |
| Angiotensin-converting enzyme inhibitors | 7 (43.8) | 17 (38.6) | 0.771 |
| Aspirin | 13 (81.3) | 39 (88.6) | 0.429 |
| Proton pump inhibitors | 3 (21.4) | 3 (6.8) | 0.145 |
| Preoperative ejection fraction | 34.64±11.174 | 40.12±11.288 | 0.121 |
| Mitral regurgitation severity | |||
| No | 7 (50) | 25 (59.5) | 0.793 |
| Mild | 5 (35.7) | 13 (31) | |
| Moderate | 2 (14.3) | 4 (9.5) | |
| Severe | 0 | 2 (14.3) | |
| Number of vessels with stenosis | |||
| 2 | 0 | 2 (14.3) | 1.000 |
| 3 | 6 (100) | 12 (85.7) |
All data are expressed as means±SDs or n (%). MCF in the EXTEM component of the (ROTEM®) test. MCF: Maximum clot firmness, EXTEM: Extrinsically activated thromboelastometric, ROTEM: Rotational thromboelastometry, SD: Standard deviation